Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV ‐monoinfected patients

Human immunodeficiency virus, elevated transaminases, fatty liver

(2019) Cai Jia et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0

(2018) L Ryom et al.   HIV MEDICINE

Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis

(2018) Raphael Mohr et al.   MEDICINE

Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection

(2018) Amine Benmassaoud et al.   PLoS One

Hypertension Among Persons Living With HIV in Medical Care in the United States—Medical Monitoring Project, 2013–2014

(2018) Oluwatosin Olaiya et al.   Open Forum Infectious Diseases

Central obesity and nonalcoholic fatty liver disease in people living with HIV: a case for targeted screening?

(2018) C Dewar et al.   HIV MEDICINE

Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy

(2018) Hugo Perazzo et al.   Journal of the International AIDS Society

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis

(2017) Thomas Pembroke et al.   JOURNAL OF HEPATOLOGY

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

(2017) Thomas Karlas et al.   JOURNAL OF HEPATOLOGY

Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients

(2016) Élise Vuille-Lessard et al.   AIDS

Prevalence and predictors of liver steatosis and fibrosis in unselected patients with HIV mono-infection

(2016) Rosa Lombardi et al.   DIGESTIVE AND LIVER DISEASE

Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices

(2016) James B Maurice et al.   JOURNAL OF HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapy

(2015) Caryn G. Morse et al.   AIDS

Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis

(2015) Pouya Azar et al.   BMC INFECTIOUS DISEASES

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

(2015) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

(2015) Robert J. Wong et al.   GASTROENTEROLOGY

Age and Ethnicity in Cirrhosis

(2015) Krishna C. Sajja et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

(2014) Juan Macías et al.   AIDS

Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case-control study

(2014) I. Vodkin et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

(2014) Colette J Smith et al.   LANCET

Liver fibrosis in HIV

(2014) Jürgen K. Rockstroh et al.   Current Opinion in HIV and AIDS

Computed Tomography Scans in the Evaluation of Fatty Liver Disease in a Population Based Study

(2012) Irfan Zeb et al.   ACADEMIC RADIOLOGY

Quality of Diabetes Care in Italy: Information From a Large Population-Based Multiregional Observatory (ARNO Diabetes)

(2012) G. Bruno et al.   DIABETES CARE

Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C

(2012) Laurent Castera   GASTROENTEROLOGY

The Burden of Diabetes and Hyperlipidemia in Treated HIV Infection and Approaches for Cardiometabolic Care

(2012) Katherine Samaras   Current HIV/AIDS Reports

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population

(2011) G. Guaraldi et al.   CLINICAL INFECTIOUS DISEASES

From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients

(2011) Maud Lemoine et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

(2010) J. K. Dowman et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

(2010) Magali Sasso et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Noreen Hossain et al.   Clinical Gastroenterology and Hepatology

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

Nonalcoholic Fatty Liver Disease in HIV‐Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors

(2008) Giovanni Guaraldi et al.   CLINICAL INFECTIOUS DISEASES

Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy

(2008) Patrick Ingiliz et al.   HEPATOLOGY